Floatz logo

Therapeutic Asset Ratings

464 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Idov-Immune
Esophageal Cancer
ViroMissile, Inc.P1C (37)
Idov-Immune
Gastric Cancer
ViroMissile, Inc.P1C (37)
Idov-Immune
Hepatocellular Carcinoma
ViroMissile, Inc.P1C (37)
Idov-Immune
Lung Cancer
ViroMissile, Inc.P1C (37)
Idov-Immune
Melanoma
ViroMissile, Inc.P1C (37)
Idov-Immune
Renal Cell Carcinoma
ViroMissile, Inc.P1C (37)
Mem-288 Intratumoral
Melanoma
Memgen, Inc.P1C (37)
Mem-288 Intratumoral
Non-Small Cell Lung Carcinoma
Memgen, Inc.P1C (37)
Mem-288 Intratumoral
Triple-Negative Breast Carcinoma
Memgen, Inc.P1C (37)
Sti-1386
Cancer
Sorrento Therapeutics, Inc.P1C (37)
TASADENOTUREV
Melanoma
M.D. Anderson Cancer CenterP1C (37)
Tilt-123
Head And Neck Squamous Cell Carcinoma
TILT Biotherapeutics Ltd.P1C (37)
Tilt-123
Lung Cancer
TILT Biotherapeutics Ltd.P1C (37)
Tilt-123
Melanoma
TILT Biotherapeutics Ltd.P1C (37)
Vrp-Encapsulated Sarna Encoding Il-12
Neoplasm
VLP TherapeuticsP1C (37)
Biottt001
Neoplasm
Beijing Bio-Targeting Therapeutics Technology Co., LtdP1C (36)
Cadvec
Breast Cancer
Baylor College of MedicineP1C (36)
Cadvec
Colorectal Cancer
Baylor College of MedicineP1C (36)
Cadvec
Neoplasm
Baylor College of MedicineP1C (36)
cf33-hnis
Cancer
Imugene LimitedP1C (36)
cf33-hnis
Neoplasm
Imugene LimitedP1C (36)
Idov-Immune
Breast Cancer
ViroMissile, Inc.P1C (36)
Idov-Immune
Colorectal Cancer
ViroMissile, Inc.P1C (36)
Idov-Immune
Ovarian Cancer
ViroMissile, Inc.P1C (36)
Idov-Immune
Pancreatic Neoplasm
ViroMissile, Inc.P1C (36)
Showing 401 to 425 of 464 assets
PreviousPage 17 of 19Next